Skip to main content

$1.51 (0%)

High

$1.54

Low

$1.51

Trades

21

Turnover

$19,629

Volume

12,937
30 June 2023 at 3:54pm
Register to track ZLD and receive email alerts.
Subject
ZLD Ann: Notification of cessation of securities - ZLD

ZLD Ann: Application for quotation of securities - ZLD

ZLD Ann: Results of Meeting

ZLD Ann: 2021 Annual General Meeting Presentation

ZLD Ann: Zelira receives $1.2 million cash R&D Tax Incentive

ZLD Ann: Partial Receipt Of Zeliras EDCDM Technology License Fee

ZLD Ann: ZLDs Phase 1 pain trial published in peer-reviewed journal

ZLD Ann: Zelira expands into NZ via exclusive distribution agreement

ZLD Ann: Letter to Shareholders

ZLD Ann: Notice of Annual General Meeting/Proxy Form

ZLD Ann: ZLD Supports Levins Chronic Pain Trial Ethics Approval

ZLD Ann: Change of Director's Interest Notice x 2

ZLD Ann: Notification of cessation of securities - ZLD

ZLD Ann: Section 708A Cleansing Notice

ZLD Ann: Notification regarding unquoted securities - ZLD

ZLD Ann: Ceasing to be a substantial holder - Tiga Trading Pty Ltd

ZLD Ann: Becoming a substantial holder

ZLD Ann: Section 708A Cleansing Notice

ZLD Ann: Application for quotation of securities - ZLD

ZLD Ann: Notification regarding unquoted securities - ZLD

ZLD Ann: Application for quotation of securities - ZLD

ZLD Ann: Zelira Develops Technology and Signs New Licensing Deal

ZLD Ann: September 2021 Quarterly Activities Report

ZLD Ann: Appendix 4C Cash Flow Report

ZLD Ann: Issue of Unquoted Options

ZLD Ann: Notification regarding unquoted securities - ZLD

ZLD Ann: Proposed issue of securities - ZLD

ZLD Ann: Zelira Raises US$5 Million from US Fund

ZLD Ann: Trading Halt

ZLD Ann: Notification of cessation of securities - ZLD

ZLD Ann: Notification of Expiry of Unlisted Options

ZLD Ann: Change of Director's Interest Notice

ZLD Ann: Annual Report to shareholders

ZLD Ann: Zelira Launches RAF FIVE Acne Treatment Products

ZLD Ann: Zelira enters Germany via Exclusive Distribution Agreement

ZLD Ann: Appendix 4G

ZLD Ann: Appendix 4E and Financial Report to Shareholders

ZLD Ann: Notification of cessation of securities - ZLD

ZLD Ann: Appendix 4C - quarterly

ZLD Ann: June 2021 Quarterly Activities Report

ZLD Ann: US Observational Clinical Pain Trial Receives IRB Approval

ZLD Ann: Pershing trading restrictions for cannabis companies lifted

ZLD Ann: Cantor Fitzgerald - Investor Presentation

ZLD Ann: ZLD to present at Cantor Fitzgerald International Conference

ZLD Ann: Clinical trial results of Zenivol published in SLEEP

ZLD Ann: Research Demonstrates Significant Uptake of CBD Into Brain

ZLD Ann: Zelira to Launch CBD Toothpaste in the United Kingdom

ZLD Ann: HHI: Expands ZLDs Distribution Agreement with CBD Toothpaste

ZLD Ann: ZLD and Levin Health to Conduct Chronic Pain Clinical Trial

ZLD Ann: Final Director's Interest Notice

Register to track ZLD and receive email alerts.

Similar Companies

CAN
CPH
EOF
IHL
MVP
MYX
NEU
PBP
RCE
SPL